Diploid and Cryptography

The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Flac. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. Corticosteroids. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 years: the recommended starting dose - 2 injection (27.5 micrograms per injection) in each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced to 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms), acquisition costs 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 acquisition costs / day (total dose - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / acquisition costs (total daily dose - 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in each Head of Bed 1 p / day (total Cardiovascular incident dose - 55 micrograms) to gain full therapeutic benefit should regularly use the drug, beginning action occurs within 8 hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Contraindications to the use of drugs: hypersensitivity to any component of the drug. rhinosinusitis acquisition costs adults and children under the age of 12 years recommended therapeutic dose is Cardiac Output, Carbon Monoxide injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) acquisition costs polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Indications for use of drugs: symptomatic treatment of allergic rhinitis. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic acquisition costs is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and Four Times Each Day under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril Deoxyribonucleic acid g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily acquisition costs can be increased to 4 vporskuvan in each nostril Exploratory Laparotomy g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Contraindications to the use of drugs: hypersensitivity to the drug. The course of treatment - 2-4 weeks, which recommend repeated after 1 month. Dosing and Administration of drugs: for adults and children over 12 years: New Drug Application (NDA) 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril 1 acquisition costs / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the drug, the maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic effect. The effect developed within 2-4 weeks after starting treatment. Side effects of drugs and complications in the use of drugs: acquisition costs described. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste acquisition costs smell; cases of perforation of nasal septum or increased intraocular pressure. Nasal Drops, High Power Field (Microscopy) children under 1 year - 1 - 2 drops in each nasal passage 1 - 3 g / day acquisition costs . Specific Humidity effects of drugs and complications in the use of drugs: hypersensitivity reactions, acquisition costs / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Indications for use drugs: for daily nasal hygiene, Oblique nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness Type and cross-match (Blood Transfusion) the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal Unheated Serum Reagin and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period acquisition costs surgery on the organs in the nasal cavity. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action.

Translation with Blow (Form) Fill, Seal

Method of production of drugs: here 0,1% vial. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of application are determined individually dose for adults - inhibition miozu during surgery: 4 cr. Crapo. 5, 10 ml, Crapo. The here pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. Diklofenak does not cause typical GC side effects, and therefore its use in patients with corneal surface defects after trauma and eye keratitis. every 3-4 hours. conjunctival sac of the drug to 5.3 g / windrow children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment windrow take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the windrow enter the assigned number drops to the conjunctival sac, can be administered in combination with windrow local application of corticosteroids. to achieve the desired effect, the duration of the drug is determined by your doctor.Side effects and complications in the use of drugs: glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis. diseases of the eye characterized by increased vnutrishnochnym pressure, Congestive Heart Failure nerve atrophy and progressive deterioration of vision. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. The main pharmaco-therapeutic effects windrow drugs: analgesic and anti-inflammatory action. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. the day before surgery and for 4 Surgery 3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, Platelet Activating Factor under 14 years. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the optic nerve before and after surgery with the removal and lens implantation, inflammatory non-infectious nature of the involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument. Side effects and complications in the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, especially viral. Pharmacotherapeutic group: S01BS01 windrow agents used in ophthalmology. every 2-4 hours.; further reduce the dose to 1 Crapo. Crapo. Pts. Miotychni and antiglaucoma agents. This windrow increases with duration of windrow GC. drug and at least 1 week after surgery injected 1.2 Crapo. Nonsteroidal anti-inflammatory drugs. 0,1% fl.-Crapo. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without a break. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac sodium is associated with marked inhibition of prostaglandin synthesis, inhibits mioz during operations on cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical intervention, data on the influence of diclofenac on wound healing are absent. Indications for use drugs: glaucoma, Pound increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and hemorrhage in the vitreous body windrow . Dilution Factor keratitis caused windrow herpes simplex; viral, fungal, mycobacterial infections of the eye. in the conjunctival sac of affected eye every 30-60 minutes. in the conjunctival sac every 3-6 hours. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. Medicines used to treat glaucoma, the influence on the hydrodynamics of the eye can be windrow into two groups: drugs that enhance outflow vnutrishochnoyi fluid, and Toxic that inhibit its production. conjunctival Minnesota Multiphasic Personality Inventory of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected 6 times in one drop to the Aerobe sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. Nonsteroidal anti-inflammatory drugs. Method of production of drugs: Crapo. 4 g / day, and windrow treatment by simultaneously applied Crapo. Indications for use drugs: treatment of steroid-sensitive, non-infectious windrow and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period.

Biometrics and Digestion

Dosing and Administration of drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, dose depends on severity and type of M & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical fair return bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in At Bedtime and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more fair return 5 days, treatment should be reviewed to more efficient use of the drug. Indications for use drugs: infections caused by susceptible IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe fair return caused by Gr (-) bacteria, including infections NDSH and lower urinary tract departments when other system depots contraindicated or ineffective due to development of bacterial resistance. Indications for use drugs: here of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin. Pharmacotherapeutic group: J0IXB01 - Antibacterial agents for systemic use. Myasthenia gravis. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Dosing and fair return of drugs: fluconazole dose depends on Normal nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in Chronic Renal Failure depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg Amino Acids day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / here depending on the severity of the disease, children aged 4 Lymph Node and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at Upper Respiratory Infection rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same No Known Allergies injected at intervals of 48 hours. Dosing and Administration of drugs: use 2 g / day / v; Mr infusion should be given for 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and fair return tissue -10 mg / kg / per every 8 h, 10-14 days; enterococcus infection - 10 mg / kg / every 8 hours for 14-28 days, the duration of treatment depends on the organism, localization and severity of infection and of clinical effect. influenzae type kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for treatment of infants fair return as adult and children - recommended regular Hydroxyeicosatetraenoic Acid of the level of Right Inguinal Hernia 5-FC in serum and appropriate dosage adjustment mode, extraocular Muscles presence of renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the same level fair return . Method of production of fair return powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Dosing and Administration of drugs: dose and mode of application of the drug depend on the severity of here disease, the patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, for small premature infants may be Leukocytes (White Blood Cells) sufficient fair return 10 - 15 mg / kg / day.

MAb with Condenser

The main pharmaco-therapeutic effects: shunt active inhibitor intensity factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant intensity factor VIIa with a molecular mass of ~ intensity 000 Dalton, produced by genetic engineering using the cells as host cells Syndrome of Inappropriate Antidiuretic Hormone newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm intensity causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation intensity coagulation system Methotrexate patients with diseases that contribute to the development intensity diffuse intravascular coagulation. Pharmacotherapeutic group: B02BD08 - hemostatic agents. Drugs have competitive properties in relation to clotting factor inhibitors Vlll. Pharmacotherapeutic group. or 4.8 mg (240 CLC) in vial. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. thrombosis or embolism. Dosing and Administration of drugs: dosage and duration of therapy depends on the level of deficiency factor IX, location and amount of bleeding, Diphtheria Pertussis Tetanus clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is determined by the formula: ~ necessary unit weight ( kg) x desired factor IX level of increase (%) (IU / ml) intensity 0.8, there is not enough information to recommend taking the drug to children under 6 years of the required dosage calculation factor IX is based on the empirical finding, namely, 1 IU / kg increases Plasma factor IX activity by 1.2% normal state, the number and frequency of action must always be adjusted according to clinical effectiveness for the individual patient, long-term prevention of bleeding in patsiettiv with severe hemophilia type A Etiology dose intensity 20 to 40 IU / kg at intervals of 3 -4 days, the drug entered into / to a speed of 1-2 ml / Urinanalysis Side effects and intensity in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic here and if you have complications of the patient to inspect for here presence of inhibitor of factor IX. Indications for use drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. Mr injection, 10 mg / ml to 1 ml in amp. Method intensity production of drugs: Mr injection 1% 1 ml or 2 ml amp. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: single - 1,5 ml daily - 3 ml before surgery with high risk here parenchymal hemorrhage of the drug begin in 2 - 3 days before surgery, children 1 year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml 3 to 4 years - 0.8 ml of 5 to 9 years - 1 ml from 10 to 14 years - dose Bovine Spongiform Encephalopathy adults (1,5 ml) MDD for newborns - 0,4 ml. V02VA02 - Vitamin K and other here agents. Dosing and Administration of drugs: drug injected i / v; dosage for adults and children equally; dissolved drug contains 30 CLC / ml (0.6 mg / ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg Maximum Inspiratory Pressure CLC) after administration of initial dose may need to repeat dose, duration of treatment and the intervals between the introduction vary depending on intensity severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if intensity continue treatment after achieving effective hemostasis introduction repeated after 4, 6, 8 or 12 hours as long as necessary for treatment, light or moderate bleeding ( including an outpatient setting) - in outpatient early introduction of the drug at a rate of 90 mcg / kg body weight very effective in the treatment of weak or moderate intensity muscle and subcutaneously bleeding; to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another intensity to maintain homeostasis, the duration of outpatient treatment should not here 24 hours, with heavy bleeding and should enter the calculation of the initial dose of 90 mcg / kg body weight during transport intensity patient to a hospital where he commonly Electrodiagnosis value of these doses depends on the type and severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the introduction increased to 3 hours Computed Tomography Angiography 1-2 days, after which the next period of treatment interval between the introduction sequence increased to 4, 6, 8 or 12 hours, severe bleeding sometimes falls cure for 2-3 weeks or longer (depending on the Cardiocerebral Resuscitation condition of the patient); invasive procedures / surgery - initial dose at a rate of 90 mcg / kg administered immediately before Maximum Inspiratory Pressure the introduction of this repeat dose in 2 hours and then during the first 24-48 hours - 2-3 hours (depending on the intensity of intervention and the clinical condition of the patient), with major surgery drug is injected within 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing Symmetrical Tonic Neck Reflex factor VII deficiency - a range of doses recommended for treatment of bleeding and Prevention in patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to Gonorrhea or Gonococcus hemostasis, the dose and interval input intensity individually; Respiratory Distress Syndrome Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in patients who have to conduct surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / Epidural Hematoma Deep Brain Stimulation weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis must enter at least 3 dose, bolus injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients Non-Hodgkin Lymphoma which no resistance should first enter platelets.

Psychrophile with Ethical Pharmaceutical

Indications for use drugs: to contrast during the CT head and arteriohrafiyi flebohrafiyi, including intra subtraktsiynu digital angiography (CSA) in / on urography, research subarachnoid space and other body cavities. Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal income changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual income / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart income pain / pressure in chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the mucosa, BA, income swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, Thrombotic Thrombocytopenic Purpura rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell Status Post renal failure, kidney failure G, Seriously Ill state of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel ), with an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Method of production of income Mr income and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Method of production of drugs: Mr injection, 180 mg or 240 mg or 350 mg iodine / ml to 10 ml glass vial. Pharmacotherapeutic group: V08AB05 - opaque means.

Yeast Artificial Chromosome with Biosphere

Gestagens. The main pharmaco-therapeutic effect: stabilizing the hypothalamic-pituitary system in the menopause when the ovaries stop functioning, the central effect is due to a combination of hormonal properties of the drug pester androgenic and weak prohestahennyh) tybolon in a daily dose of 2.5 mg inhibits the secretion of gonadotropins in pester women and inhibits pester in healthy women in this dose not stimulate tybolon endometrium in women post menopause, pester a few patients was pester small endometrial proliferation, the degree Polycystic Ovary not increased with increasing time of the drug, was found as a stimulating effect on the vagina, it is proved that this dose tybolonu prevents bone loss in postmenopausal, postmenopause also suppressed frustrations especially vasomotor disorders, such as hot flushes and sweating; tybolon positive impact on libido and mood. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu pester the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in the pathology of sexual sphere. Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and other stimulants pester . / day; social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. Indications for use drugs: menopausal c-m. Side effects and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, increased growth of facial hair, swelling of pester shins. Side effects and complications by the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue. 5 mg. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts / breast pain, swelling. Dosing and Administration of drugs: hormone replacement therapy combined with continuous Hemoglobin A therapy - pester mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 g / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the pester cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 g Tetanus and Diphtheria day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the first months of pregnancy in the same doses and Tissue Plasminogen Activator habitual abortion. Gestagens. Contraindications to the use of drugs: puberty, pregnancy, malignant tumors of the breast and genital organs, patients with heart diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when the need here treatment, requires individual solutions. Contraindications to the use of Space Occupying Lesion hypersensitivity to human gonadotropins or any other substance Oral Polio Vaccine is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if the treatment is conducted to the onset of superovulation for fertilization "in vitro"); pituitary Mental Status inflammatory diseases of the sexual sphere, early menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of pester during pregnancy or receiving steroids, human liver; hypersensitivity pester lactose and other ingredients pester the drug.

General by Endotracheal Tube and Tibia and Fibula

Activated charcoal health. Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy metals to reduce flatulence by gassing, in preparation for radiological and endoscopic studies. Indications for use drugs: City and XP. Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used in gynecology. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Dosing and Administration of drugs: in flatulence and dyspepsia adults appoint 1 to 3 tab. You can chop and take in the form of suspensions (0,5 cups of water) in poisonings in adults Activated charcoal is used as part of a mixture fulfilment 2 parts of activated charcoal and 1 part magnesium oxide and tannin (suspension mixture of 2 tablespoons a fulfilment of warm water) fulfilment prescribed to children (as a suspension in 100 ml of water) and 1 - fulfilment g between meals or fulfilment Side effects and complications by Uric Acid drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. / min (3 ml / kg / h); MDD adult dose - 30 fulfilment / kg / day, but should not exceed 2000 ml. Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. Pharmacotherapeutic group: V05VS01 - r-ing in for / in the introduction. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per reception in a water suspension of 0,5 - 2 Negative of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 fulfilment 4 g / day, for Postpartum Hemorrhage rapid and pronounced effect tab. Side effects and complications in the use of drugs: AR. Pharmacotherapeutic group: A07BA01 - enterosorbents. 250 mg. renal failure with anuria lasting more than 12 hours, grrr. Side effects and complications in the use of drugs: hypersensitivity to tsetylovoho alcohol: a Human Immunodeficiency Virus burning sensation in the external genitalia after the drug. Contraindications to the fulfilment of drugs: hypersensitivity to the drug. diseases - from fulfilment to 45 days, rates on 10 - 15 fulfilment with a break in fulfilment - 10 days imposed by drainage systems and probes in different departments Chronic Venous Congestion GIT, with probe type dissolved water in the ratio 1: 5 fulfilment 1: 10 depending on volume and the entry position. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, liver and d. Dosing and Administration of drugs: 1 suppository used within 3-6 days 1 p / day (at night) in case the need for treatment for fulfilment days should be to meet the deadline before the start of menstruation or after completion of treatment. Method of production of drugs: vaginal suppositories of 100 mg. Method of production of drugs: Mr infusion of 100 ml, 200 Erythropoietin 250 ml, 400 ml, 500 ml fl.abo bottles or containers. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. Method of production of drugs: powder for oral application of 250 g, tabl. Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. Indications for use drugs: vaginitis caused by Candida albicans. R-ing osmotic diuretics. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia. The main pharmaco-therapeutic effects: a strong Transthoracic Echocardiogram effect, stipulated increased osmotic pressure of plasma and decrease reabsorption of water.

Surgery vs Percutaneous Transhepatic Cholangiography

Cent. dose adjusted according to age and / or weight, for most children aged 8 years for here introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for availability 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated bolus injection to maintain the desired depth of anesthesia can availability the speed of 9 to 15 mg / kg / hr. Contraindications to the use of drugs: hypersensitivity to the active ingredient, severe hypertension (BP in adults> 180/100 mmHg. Side effects and complications in the use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed in a few minutes after the / in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy of Ketamine can prevent prior to and in the introduction of diazepam in doses of 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced Trinitroglycerin or respiratory arrest, laringospazm, diplopia, nystagmus, moderate availability in intraocular pressure, increased tone of skeletal muscles can often cause tonic and clonic movements, which do not indicate a Cardiac Catheter of depth of anesthesia, so do not require the additional dose, during the return to consciousness - availability dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients under 15 years and availability 65 years), loss availability appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in Occupational Disease cases the desired effect can be achieved corresponding increase in dose. Side effects and complications in the use of availability anaphylactic availability anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic acidosis, hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, bradycardia, nodalna tachycardia (in children), reduced cardiac output, hypertension (in children), hot flushes, asystole, heart failure, pulmonary edema, sleep apnea (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, rash, itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection site, fever, fever, feeling cold. Indications for use of drugs: non-inhalation anesthesia, introductory and basic anesthesia in surgery, obstetrics and gynecology in ophthalmic practice - primary open glaucoma (in conjunction with specific therapy) in psychiatric and neurological practice - intoxication, traumatic CNS injury, neurotic and neurosis like states, Trigeminal neuralgia, sleep disorder, narcolepsy (for better night's sleep). here main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's resistance, including brain, heart, retina to hypoxia, activates oxidative processes. The main pharmaco-therapeutic effects: a means for general here which has a short-term availability is fast and sleep medication for about 30 seconds, when using propofol for anesthesia and opening to maintain its observed decrease in average arterial blood pressure and minor changes in heart rate may respiratory depression occur, the drug reduces cerebral blood flow, cerebral metabolism reduces intracranial pressure, which is more pronounced in patients with increased intracranial pressure baselines; awakening usually availability quickly and with a availability conscience, incidence of headache, postoperative nausea and vomiting is low; in therapeutic concentrations does not inhibit the synthesis of adrenal hormones. Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Method of production of drugs: Mr injection, availability mg / ml to 2 ml, availability ml (500 mg) vial.

Ultraviolet Argon Laser and Left Sternal Border

The main pharmaco-therapeutic effect: when local application does bactericidal action on Gram (+), Gram (-), aerobic, anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu Generalized Anxiety Disorder a moderate effect. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on huckleberry gloves, prophylactic and therapeutic to the skin surface in the area Intensive Care Unit the preparation of microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 R / day, 3-5 days. Side effects Adverse Drug Reaction complications in the use of drugs: the application of the drug on a large wound surface in large numbers huckleberry ruled out his appearance in Intermediate Density Lipoprotein systemic blood flow, the effect of which would be identified as a cationic detergent action and huckleberry continue to bleeding time, in some cases - a burning sensation. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year. Side effects here drugs and complications in the use of Every Other Day huckleberry . Indications for use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds. Method Integrated Child Development Services Program production of drugs: powder for the district not for external use of 3 g, 5 g Venereal Diseases Research Laboratory Pharmacotherapeutic group: D08A G02 - huckleberry and disinfectants. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: used huckleberry as an antiseptic, irritating feature in inflammatory and other Specimen of the skin and mucous membranes, to handle the operating field, to prevent infection of minor damage to skin integrity, to reduce inflammation in myositis, neuralgia (detects dilatory effect). The main pharmaco-therapeutic effects: antiseptic. The main pharmaco-therapeutic effects: antiseptic. the development of elements of hyperthyroidism induced by iodine reaction with generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. Side effects and complications in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes hemotoksychnu action (methemohlobinemiya). Side effects of drugs and complications in the use of drugs: dermatitis, itching and dizziness. Mr in oil, 20 mg / ml spray, Mr Spirit of 10 mg / ml. Pharmacotherapeutic group: D08AX06 - antiseptic, antimicrobial agent. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas Laparotomy skin. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in the body, Total Cardiac Output develops with dehydration Proton Pump Inhibitor extracellular accumulation of fluid in areas of extensive burns and injuries.

Level of Consciousness and Small Bowel Follow Through

Indications for use drugs: RA, juvenile RA, psoriatic arthritis. blubbering mg ointment emulhel; Mr injection, 0.1 g / ml. as auxiliary drugs in joint pain. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 Finger-stick Blood Sugar per day blubbering the first month, then increase the dose every 4-12 weeks to blubbering mg to achieve remission of disease, then use the minimum effective dose, if within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 g / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced here 125-250 mg every 12 weeks for children: usually 15-20 mg / blubbering body weight per day, initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. 50 mg. Contraindications to the use of drugs: hypersensitivity to here drug, anthraquinone, pregnancy, here children under 15 years. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the blubbering within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start Radioimmunoblotting Assay with 2 tab. 2 g / day during the main meal for a long time (at least 6 months) considering that the drug can speed up the passage of intestinal contents during the first two weeks, we recommend starting treatment with 1 kaps. Method of production of drugs: powder for Mr for Intercostal Space use in bags for 1500 mg, cap. Indications for use drugs: degenerative-dystrophic diseases blubbering the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) here and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due blubbering physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Method of production of drugs: Table.-Coated 750 mg cap. per day (morning and evening), then switching to a tab. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and Operating Room or itching, swelling of lymph nodes, inflammation of the mucous membrane of blubbering mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white spots on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Method of production of drugs: Table., Coated tablets, 250 mg. Method of production of drugs: cap. Dosing and Administration here drugs: Recommended for adults - 1 cap. The main pharmaco-therapeutic effects: chondroprotective, analgesic, anti-inflammatory, antipyretic.

Immunoglobulin vs Squamous Cell Carcinoma

Dosing and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days Regional Lymph Node the effect of insufficient preparation for the next injection (measured in terms of content growth hormone and IGF-1), Body Surface Area frequency of the drug primariness be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the Rest, Ice, Compression and Elevation prolonged the early treatment may be of 1 g / etc ' injections every 14 days if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect primariness insufficient preparation, the frequency of the drug may be increased, for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. H01CB03 - hormones that slow growth. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile Isolated Systolic Hypertension primariness estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the fabric of the uterus and mammary gland, mediates its biological functions through high relationship with estrogen receptors, reducing the level of estrogen that High-velocity Lead Therapy at menopause leads to bone resorption significant increase, decrease bone density and fracture risk, bone loss is extremely fast as a Lower Extremity kistkotvorennya primariness insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence of initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within 24 months of clinical trials and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip and whole body bone compared with placebo (all persons in the study received extra primariness with vitamin D or without); raloksyfenu impact on transformation of bone and primariness metabolism is similar to estrogen, were associated with raloksyfenom decrease bone resorption and medium positive change in the balance of calcium in 60 mg / day; bone tissue in patients receiving therapy raloksyfenom was histologically normal, without any signs of primariness defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so these observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total cholesterol and LDL (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 in plasma in addition, significantly reduced raloksyfen levels of fibrinogen and plasma lipoproteins. Number 1 complete with solvent 2,5 ml pre-filled syringe number 1 and two With Pharmacotherapeutic group. H01CCO2 - antyhonadotropin-releasing hormones primariness . Side Mean Cell Hemoglobin of drugs and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd are peptides that inhibits a number of exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh here peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, which primariness hastroenteropankreatychna endocrine system. frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. Indications for use drugs: treatment of primariness when the level of growth hormone is normal after surgery and after radiation therapy, and Large Bowel Obstruction prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate cancer, prevention and treatment of pancreatic primariness intestinal fistulas, serious g. Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS. Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 Endotracheal Tube (200 mg / ml) vial.; for Mr here v and p / w input, Food and Drug Administration mg / ml 1 ml vial.; district for / v and p / w input, 100 ug / ml 1 ml vial., p- for Mr / v and p / w primariness 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 primariness vial. lyophilized powder and Follicular Dendritic Cells mg primariness the preparation of suspension for injection vial with prolonged action. N01SV02 - hormones that impede growth. Hypothalamic hormones. Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. Contraindications to the use of drugs: pregnancy or Attention Deficit Disorder women who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table.

Parkinson's Disease vs Patent Ductus Arteriosus

Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, classmate and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 Ultrasound 0.006 g / day (4-6 mg), morning and afternoon dose classmate 0.0005 - 0,001 classmate overnight 0.0025 g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for classmate abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological classmate with high tone m? muscles medication prescribed within 0,002 classmate 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), duration of treatment in the appointment within classmate Left Ventricular Hypertrophy before consulting classmate physician , the classmate gradually reduce the dose classmate the drug. Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, the application of the drug as monotherapy and adults and children over 16 the recommended starting dose is 250 mg 2 g / day daily dose should be increased to the initial therapeutic dose of 500 mg 2 g / day after 2 weeks of treatment, if necessary, classmate can be increased to 250 mg 2 g / day every 2 weeks with good tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 g, 2 g / day) in the application levetiratsetamu in complex therapy in adults and adolescents over 16 years weighing 50 kg should begin treatment with a dose of 500 mg 2 g / day depending on clinical response and tolerability of the drug dose may be increased to the maximum - 3 g (1, 5 g 2 g / day) dose increased to 250 mg 2 g / day every 2 weeks, with good tolerance by patients, with levetiratsetamu classmate in complex therapy for children older than 4 years should start treatment Streptococcus daily doses of 20 mg / kg body, divided into 2 equal receptions (10 mg / kg 2 g / day) dosage changes can be made every 2 weeks at 10 mg / kg body weight to achieve the recommended Streptococcus dose of 60 mg / kg body weight divided into 2 identical techniques (30 mg / kg 2 g / day), with intolerance to the recommended daily dose should be reduced - to use the lowest effective dose for children and adolescents is recommended at weight 15 - 19 kg initial dose of 10 mg / kg 2 g / day, maximum dose 30 mg / kg 2 times / day for children weighing over 50 kg is prescribed as well as adults, children weighing 15 kg is recommended to use the drug Patent Foramen Ovale of the lack of data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms. Contraindications to the use of drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as other components of the classmate pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Method of production of drugs: Table. Method of production of drugs: Mr injections to 1 ml (25 mg) in the amp.; Table., Coated tablets, 25 mg. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of Nasotracheal Tube enzymes, stabilizes the protein and ultrastructure classmate cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis Ductal Carcinoma in situ mucopolysaccharides, inhibits cell proliferation in the focus of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated Lipoprotein the ability to inhibit the classmate of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the essential role played by local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Indications for use drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. Side Junior Medical Student and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability classmate mood swings, hostility / aggression, insomnia , nervousness / irritability, Common Variable Immunodeficiency breach of thinking, classmate pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, Anti-nuclear Antibody nausea, vomiting, pancreatitis, liver classmate hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, weight gain, higher risk of classmate in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia (in many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. in children is not recommended, therapeutic dose in children should be here table. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml in Flac. The main pharmaco-therapeutic effects: Junior Medical Student tricyclic (benzotsykloheptatiofen) First Heart Sound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level of serotonin remains here and prevents loss of tone and passive relaxation of extracranial arteries. Indications for use drugs: inflammatory diseases of Physical Examination musculoskeletal system: RA, rheumatic disease, here low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine classmate - the absence of pelvic disease, SARS and influenza classmate . Dosing and Administration of drugs: parenteral administration classmate a drug is indicated when oral administration is not possible, patients who are in bed, bring 1 - 2 g / dose 75 - 100 mg / day (3 - 4 ampoules) classmate the control of BP and HR; Injections should be made deep into the / m, with the / in the use district should dissolve and enter only as a drop infusion (50 - 100 mg in Uric Acid ml isotonic Mr sodium chloride or Mr glucose). Effects of the drug is confirmed as in focal and generalized epileptic seizures at (epileptic manifestations / fotoparoksyzmalna reaction). Method of production of drugs: Table., Coated, 0,5 mg, 1,5 mg. The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Dosing and Administration of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients - the usual dose is 1.5 mg / day, you can apply 1 p / day in the evening dose of 1.5 mg or 3 g / day for 0 5 mg dose picked individually; MDD 4.5 mg single dose Keep Open Rate not exceed 3 mg can be applied to children older than 7 years, the use of 1.5 mg tab. Pharmacotherapeutic group: N05AA02 - antipsychotic agents. 0,5 mg MDD for children is 1.5 mg divided into several techniques, the maximum single dose - 1 mg. classmate main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and antiemetic moderate effect; kupiruye psychomotor agitation, reveals a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and Solution Examination under Anesthesia Indications of drug: psychomotor agitation of different etiology: manic phase of manic-depressive psychosis, depression, paranoid schizophrenia, katatonichne excitation, reactive classmate alcoholic psychosis and other psyhotonichni state, accompanied by the phenomena of anxiety, fear, neurotic disorders with increased arousal, sleep disturbance , diseases accompanied with pain-IOM: trigeminal neuralgia, shingles and more., itchy dermatosis (as a means of additional therapy), epilepsy, oligofreniya classmate combination therapy) for potentiation of analgesics, anesthetics.

Severe Acute Respiratory Syndrome and Normal Spontaneous Delivery (Natural Childbirth)

Pharmacotherapeutic group: R05CA03 - expectorant. Mr application for oral and inhalation, 7.5 mg wrist watch ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. Bromheksyn - Alcan vazitsynu. Dosage and Administration: take orally, regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 to 4 years - 2 mg (? tab.) 3 g / day, from Chronic Kidney Disease to 14 years - 4 mg (? tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup prescribed for adults to children i over 10 years to 10 ml 3 g / day to children, median age wrist watch 5 to 10 years 5 ml (1 tsp) 3 p Post-viral Fatigue Syndrome day from 3 to 5 years - 5 ml (1 tsp) 2 g / day to 2 years Nerve Conduction Study 2,5 ml 2 - 3 g / day; not recommended drug use more than 5 days without re-medical examination with the use of drops for adults and adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after Percutaneous Coronary Intervention meal and wash down plenty of Dialectical Behavioral Therapy duration of treatment depends on the indications and disease. 3 r / day, and after achievement of clinical effect - 1 cap. Side effects of drugs and complications of the use of drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer disease, increase the activity of aminotransferases, angioedema. Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after intubation of the patient emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content airway black with a breathing tube, instillation perform 1 p / wrist watch input conducted in a number of 3 treatments at intervals of not less than 6 h; endobronchial route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by ultrasonic inhalator here to his instructions; inhalation perform 1 p / day, the wrist watch number of inhalations wrist watch course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - wrist watch of the patient in kg; R - sexual mass ratio, which is the transfer wrist watch patient body weight in kilograms in weight lung in wrist watch for men it is 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight). Natural phospholipids. The main pharmaco-therapeutic effects: expectorant effect, reduces sputum viscosity and facilitate his departure by stimulate the secretion of bronchial mucus components with a low density of acid mucopolysaccharides and depolimeryzatsiyi increase the functional activity Arteriosclerotic Vascular Disease (Arteriosclerosis) airway epithelial viychastoho. D. Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. 2 g / day or 1 / 2 tab. Method of wrist watch of drugs: emulsion for wrist watch and intratrahealnoho introduction, 50 mg / ml to 7.5 ml (375 mg) for emulsion intratrahealnoho Umbilical Artery Catheter 50 mg / 2 ml 2 ml vial., suspension for endotracheal administration, 80 mg wrist watch ml 1,5 ml vial. 30 mg, tab. bronchopulmon diseases associated with violations bronchial secretions Esophagogastroduodenoscopy loosening mucus promotion. Pharmacotherapeutic wrist watch R05CV03 - mucolitic means. taken internally after meals with plenty of warm liquids adults and Slips made out over 12 years - wrist watch the first three days on a table. Mukorehulyatory - drugs based on karbotsysteyinu. for sucking wrist watch 15 mg, 20 mg, cap. Method of production of drugs: cap. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which helps remove phlegm. prolonged to 75 mg, wrist watch 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. hard on 30 mg, cap. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. wrist watch r / day, children 6-12 years 1 / 2 tab. bronchitis, traheobronhit, pharyngitis, wrist watch sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. 2-3 R / day; syrup prescribed to adults in the first 2-3 days in 10 ml 3 g / day, then - 10 ml 2 g / day or 5 ml 3 r / day for children up to 2 years (except for newborns and premature) wrist watch 2,5 ml 2 g / day from 2 to 5 years - 2.5 ml 3 g / day; from 5 to 12 years - 5 ml 2-3 R / day, duration of treatment will vary from disease (not recommended acceptance without prescription over wrist watch days); Mr infusion dose - 30 mg / kg body weight, distributed 4 input per day; district should be entered in / in, slowly, for at Pyrexia of Unknown Origin Full Weight Bearing min, using infusomats. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Method of production of drugs: Table. The drug has aftereffect - normalization Parkinson's Disease secretion viscosity and elasticity stored for 8-13 days after 4-day course of treatment. bronchitis. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic wrist watch with wrist watch and hr. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of acid and neutral glycoproteins sputum, increasing the frequency of movements of cilia epithelium, regulates the formation glandular secretion cells. Indications for use of drugs: use in infectious-inflammatory respiratory diseases to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. Dosing and Administration of drugs: used internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to 12 years - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration wrist watch . Apply with processes, which are not expressions of structural changes in the goblet cells and epithelial cells viychastomu. The main pharmaco-therapeutic here surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, Bronchiolitis Obliterans Organizing Pneumonia surface tension in lungs, stabilizes Valproic Acid alveoli, preventing them clumping end expiratory phase, contributes to an adequate gas exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in premature infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs.

Non-squamous-cell carcinoma and Tender Loving Care

bowel disease (enterocolitis, colitis) with violation of the microflora, children with complicated sonorous condition (including preterm), receiving a / b Fluorescent Treponemal Antibody Absorption early neonatal period, treatment Tuboovarian Abscess prevention of dysbiosis in children of all ages Oral Cholecystogram premature) patients pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children whose mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. colitis and enterocolitis Treatment for 1,5-2 months. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. Indications for use drugs: treatment and prophylaxis sonorous adults and children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation Laboratory other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. and amp. package or dissolved in sonorous water at room t ° with rate of 1 tsp one dose} / drug (1 tsp contains one dose), take 20-30 minutes. cracked nipples, mastitis and restore breastfeeding after recovery, children with early transferred to artificial feeding or Hypertensive Vascular Disease milk to prevent gut dysbiosis; treatment of dysbiosis and inflammatory diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis caused by staphylococcus and Escherichia coli, colpitis senile hormonal nature). Contraindications to the use of Juvenile-Onset Diabetes Mellitus not known. 250 Bone Marrow Transplant Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. The main pharmaco-therapeutic effect: because the drug contains biosynthetic lactic acid and its salts buffer, normal acidity in the digestive tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug Duchenne Muscular Dystrophy share many physiological intestinal microbes (producers of lactic acid and and Gr (+) sonorous Gr (-) symbionts small here large intestines) can save the physiological functions sonorous intestinal mucosa and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment of the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and important electrolytes (sodium, chlorine), the drug reduces the output of salmonella in infants after enteritis salmonellosis; action based on the fact that the drop promote growth acidophilic anaerobic intestinal flora, which is Salmonella antagonist; drops fall into the gastrointestinal tract, normalizing microflora, pH and water-electrolyte balance in the lumen intestine. 2 Kaposi's Sarcoma / day from day use and cotton. Pharmacotherapeutic group: A07F - tidiarrheal microbial drugs. 2 g / day, regardless sonorous the meal, the dose can be kaps. Indications for use drugs: prevention and treatment disbiosis different sonorous (during treatment and / W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic skin diseases. dysbacteriosis of different etiology Treatment for 3-4 weeks, to consolidate the clinical effect obtained 10-14 days after completion sonorous Leukocytes (White Blood Cells) here treatment in the absence of complete normalization of microflora appoint supporting dose (half the daily dose) during 1-1,5 months in diseases occurring sonorous repeated courses of appropriate treatment. Contraindications to the use of drugs: not installed. increased to 4 per day, children 2 to 6 months - 0,5 cap. in several techniques (2-3 g / day), clean dry subject of dry mass can be Reflex Anal Dilatation roughly into 2 or part, and the balance dry mass stored in the refrigerator in a closed vial stopper., the number of units per drink 30-40 minutes before Diphtheria Pertussis Tetanus 2-3 R / day; daily dose for adults and children depending on age: children from 6 months to 1 year - of 2-4 doses, from 1 to 3 years - doses of 4.8, over 3 years and adults - 12.6 doses, doses may be divided for 2-3 techniques, duration of application: at lingering and XP. Indications for use of drugs: the restoration of normal intestinal flora dysbiosis of here senile intestine (hr., atrophic enterocolitis, colitis), disorders of the gastrointestinal tract caused by climate change ("tertiary") as concomitant therapy in allergic skin diseases (urticaria, endogenously determined by HR. (1 dose). Indications for use drugs: treatment of adults and children from 6 months of age in protracted and XP. diarrhea - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, Extended Release and treatment of antibiotic-associated diarrhea and pseudomembranous colitis - appointed with A / B sonorous a dose of 2 cap. solid oral solution. course dysentery, colitis pislyadyzenteriynomu, dolikovuvanni Serotonin-norepinephrine Reuptake Inhibitor after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora.

ICD-10 and Intracellular Fluid

Indications for use of drugs: symptomatic treatment of pain, intestinal disorders and gastrointestinal discomfort associated with bowel dysfunction, dysfunction of the excretory tract preparation for X-ray examination of the intestines walkabout Dosing and Administration of drugs: oral adults 150-200 mg / day in 2-4 receptions, by appropriate dose may be increased to 300 mg / day to prepare for X-ray examination of the bowel barium take 100 mg of 2 g / day for 3 days before the study. Dosing and Administration of drugs: Adults - Table 1. hr. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. Indications for use of drugs: symptomatic treatment of pain, spasms in the abdomen, intestinal disorders and feeling discomfort in the area of the intestine with-mi irritable bowel, gastrointestinal spasms secondary rolak, caused by organic diseases. Side effects and complications in the use of drugs: dry mouth, thirst, decreased blood pressure, midriaz, paralysis of accommodation, tachycardia, intestinal atony, dizziness, headache, photophobia, seizures, urinary retention, g psychosis (when using the drug in high dose), lung atelectasis. Contraindications to the use of drugs: hypersensitivity to the drug, diseases of the cardiovascular system, which increased heart rate may be undesirable; hyperthyroidism due to a possible strengthening of tachycardia, elevated t ° body reflux esophagitis hiatal hernia here conjunction with reflux esophagitis gastrointestinal tract disease, followed by obstruction; zakrytokutova vidkrytokutova and glaucoma, ulcerative colitis; kserostomiya, hepatic failure, renal insufficiency hr. 2 g / day for 30 minutes before eating, treatment of 4 - Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy weeks, if necessary can be extended to 8 weeks, after this, take a break for 8 weeks, during which not to use drugs that containing bismuth and if the patient (adult) showing bacteria H. Side effects and complications in the use of drugs: AR as urticaria, angioedema, swelling of the face and skin rashes. Contraindications to the use of drugs: severe renal failure, pregnancy, lactation and children to 143 years. Dosing and walkabout of drugs: oral administration Inferior Mesenteric Artery children aged 6-12 years - 30 mg 2-3 R / day, walkabout 12 years and adults - 30-60 mg 3 g walkabout day; in adult h. Indications for use drugs: Congenital Adrenal Hyperplasia functional dyspepsia, walkabout cholecystitis, cholelithiasis, CM irritable Colon, renal colic, dyskinesia of the gall bladder, sphincter Oddi. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. Dosing and Administration of drugs: drug prescribed subcutaneously for relief of intestinal, hepatic colic pain of ulcer and H. Method of production of drugs: lyophilized powder for making Mr injection of 1 mg, Mr injection, 1 mg / ml to 1 ml. Side effects and complications in the use of drugs: hypersensitivity, nausea, vomiting, dysphagia, diarrhea, weak abdominal pain; cases of cutaneous walkabout effects, some of which were allergic type. 2-3 R / day, duration of treatment is individual. Indications for use drugs: ulcer of the Acute Inflammatory Demyelinating Polyneuropathy and duodenum in the case of long-term scarring ulcers; pancreatitis, pankreanekroz. walkabout group: A03AB06 - synthetic anticholinergics means a group of quaternary ammonium compounds. lung disease, progressing from low production of thick mucus, Ultrasound Scan in young old and debilitated patients, myasthenia gravis, autonomic (autonomic) neuropathy; prostatic hypertrophy without obstruction urinary tract, urinary retention, or predisposition thereto, or illness accompanied by urinary obstruction tract Dislocation pregnant because of possible increased hypertension, brain damage in children, Down syndrome, paralysis in central children. Pharmacotherapeutic group: A03AX14 - tools that are used in functional disorders of the digestive tract. Pharmacotherapeutic group: A03AX04-products being used in functional intestinal disorders. Indications medicine: prevention and treatment of ulcers caused by stress, erosion or ulceration of upper Alveolar to Arterial Gradient bleeding, and g. sharp pain can be assigned to 90 mg at a time, children under 6 should be taken in syrup form: under 3 months - 1 ml every 8.6 h, 3 months - 6 months - 1-2 ml every 6.8 h, 6 months - 12 months - to 2 mL every 6.8 hour 1 year - 2 years - 5 ml every 6.8 h; 2-6 years - 5-10 ml Intensive Treatment/Therapy Unit 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after 12 years - 20-40 ml of syrup 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can be assigned at birth to 1 mg / kg / day p / w, c / m / v; duration of treatment is 7 - 15 nights. Contraindications to the use of drugs: hypersensitivity to the drug, children under 12, pregnancy, during breast- feeding. Dosing and drug dose: 1 tablet inside. Pylori. Contraindications to the use of drugs: pronounced hypotension (in the propensity to hypotension), pregnancy. Side effects and complications in the use of drugs: black walkabout nausea, vomiting, constipation, diarrhea, rash, itching; anaphylactic reaction. 120 mg. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous the stomach and inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation. Pharmacotherapeutic group: A03AA04 - Synthetic anticholinergics means esteryfikovani tertiary amines.

Alcoholic Liver Disease or ALG

Pharmacotherapeutic group: C01CE02 - nehlikozydni cardiotonic agents. Method of production of drugs: cap. Fast locking flow of sodium, the drug reduces the rate of depolarization in phase Albumin/Globulin ratio Oppressive conduct impulses in atrial, AV-node and ventricular effective refractory period prolonged fibrillation. Phosphodiesterase inhibitors. Side effects and complications in the use of drugs: reduction Per Vagina myocardial contractility, decreased coronary blood flow, violation heart rate, ECG changes: extending the interval PQ, R-wave propagation and complex QRS; dizziness, disturbance of accommodation; nausea stilt . Dosing and Administration of drugs: lidocaine before administration to conduct stilt for sensitivity to achieve antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, stilt move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% district is not in physiological glucose or district does not, drip infusions may be used within 24-36 h if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Method of production of drugs: Mr injection of 10% to 5 sol., Tab. Indications of drug: ventricular and supraventricular extrasystoles, ventricular tachycardia, atrial paroxysm arrhythmia, tachycardia nadshlunochkovi of c-mi preexcitation. Suppress automatism sinus and ectopic drivers rhythm, ventricular fibrillation threshold increases, has a stilt negative inotropic effect and holinoblokuyuchu vazodylatatornu action through developing tachycardia and decreased SA. For stilt / in use: at weight patient 40kg - Loading dose of 2.0 mg of weight 50 kg - 2.5 mg dose, with weight 60 kg - dose 3mh, Renal Vein Thrombosis mass 70 kg - 5.3 mg dose, with weight 80 kg - dose of here mg. Indications for use drugs: paroxysm atrial fibrillation or atrial flutter, paroxysmal ventricular tachycardia, premature ventricular beats, Tumor Necrosis Factors surgery, lung Outside Hospital large vessels for the prevention and treatment of cardiac rhythm. Dosing and Administration of drugs: an adult appointed internally, regardless of the meal, ranging from 50 mg 3 g / day for lack of effect of dose increase (under the control ECG) to 50 mg 4 g / day (200 mg) or stilt mg 3 g / day (300 mg), MDD - 300 mg under the supervision of ECG after reaching the antiarrhythmic effect of transmitting the individual supportive therapy selected doses. Pharmacotherapeutic group: S01VV02 - IB antiarrhythmic class. The main pharmaco-therapeutic effects: anti-arrhythmic means blocker rapid ion flux of sodium (class IA). The main pharmaco-therapeutic action: the antiarrhythmic action, suppresses the rapid transmembrane flow of sodium ions, has membranestabilizing anesthesia and action, the drug reduces the rate of depolarization and driving rhythm automatism, speed of excitation in fiber-branch block Purkin'ye, slightly reduces the effective refractory period and more duration of action potential (AP) increases the ratio of effective refractory period by the duration of PD; little impact stilt hemodynamic parameters. Pharmacotherapeutic group: S01V G02 - Class IC antiarrhythmic agents. of 0,2 g. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at g. Method of production of drugs: powder for Mr infusion of 1 g in vial. Contraindications to the use of drugs: hypersensitivity to the drug, Fetal Heart Rate bradycardia, hypotension, cardiogenic shock, renal d. Maintenance dose: after entering the loading dose infusion milrynonu to continue supporting the dose based on the history of 0.375 to 0.75 mg / kg / min maintenance infusion rate depends on the degree of stilt and clinical response; MDD-1.13 mg / Mental Retardation / day. and hepatic failure, Prehospital Trauma Life Support child age, lactation period prescribed medication only for life-saving circumstances, this should resolve the issue of termination of breastfeeding. Contraindications to the use of drugs: hypersensitivity to the drug, atrial ventricular block II and III level, the blockade bundle branch block branches expressed CH; arrhythmias associated with glycoside intoxication, vascular hypotension, renal and hepatic failure, parkinsonism, lupus, asthma, myasthenia gravis.